Stay updated on Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    A new Revision: v3.4.2 tag was added and the earlier Revision: v3.4.1 funding-status notice was removed, which are maintenance updates that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T12:47:05.000Z thumbnail image
  3. Check
    21 days ago
    Change Detected
    Summary
    Added a government funding lapse notice and NIH operations status; updated the site to version 3.4.1 and removed the 3.4.0 reference. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T10:14:37.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    A glossary toggle was added to the page. Minor metadata updates were made, including the label 'Last Update Submitted that Met QC Criteria', capitalization of 'No FEAR Act data', and the revision note 'v3.4.0'.
    Difference
    0.2%
    Check dated 2026-01-28T05:10:04.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.3.4 is now shown, replacing Revision: v3.3.3. This is a minor UI/version update and does not alter study details or user actions; To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:11:50.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Added a Locations section listing state sites (Arizona, California, Colorado, Massachusetts, New Jersey, Pennsylvania, Washington) and updated the revision to v3.3.3. Removed the HHS Vulnerability Disclosure link and the previous revision tag (v3.3.2).
    Difference
    0.8%
    Check dated 2025-12-23T20:37:49.000Z thumbnail image
  7. Check
    91 days ago
    Change Detected
    Summary
    Revision entries were updated to v3.3.2 and v3.2.0 was removed, reflecting internal version control rather than substantive changes to the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T11:24:03.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Refractory Metastatic Colorectal Cancer Clinical Trial page.